Skip to content
Tirzepatide Report
Provider review

Corsica Tirzepatide Review: Monthly Price & Refund Scope

Published by Tirzepatide ReportUpdated

On this page

$299 one-month tirzepatide option or $747 three-month plan; guarantee and final-sale scopes differ.

Standout details

  • Current one-month and three-month purchase amounts published
  • Medication, injection supplies and portal listed

Things to consider

  • Three-month equivalent is a longer commitment
  • First-month satisfaction and prescription final-sale clauses need clarification

Corsica Health publishes a $299 one-month tirzepatide option and a $747 three-month plan, advertised as $249 per month. The lower monthly figure describes a longer purchase. Its product page says the card is charged only if a licensed healthcare provider approves treatment.3

Compare the full purchase

The named injection page includes medication, injection supplies, alcohol swabs and a secure patient portal. Its FAQ describes provider access and support within the subscription. Confirm the selected supply, payment schedule and next charge before authorizing a recurring plan; the one-month option and three-month total are different commitments.3,4

DecisionPublished condition
One-month option$299 advertised
Three-month plan$747 total; $249 monthly equivalent
Product inclusionsMedication, injection supplies, alcohol swabs and portal
Clinical approvalCard charged only if provider approves, per product page
All-dose pricingNot established for every dose/future refill
Public plan figures are distinct commitments, before any conditional checkout promotion.

A displayed checkout code is not a guaranteed continuing rate. The published prices above are the plan amounts before any eligibility-dependent discount; the checked product body does not establish that every dose or future refill has the same price.3

Clinical review comes before approval

Corsica's FAQ identifies Telegra MD in its provider-information process. The Terms name Corsica Therapeutics LLC as the website operator and distinguish the platform from independent medical professionals, pharmacies and laboratories. These disclosures explain responsibility; they do not verify an individual clinician's license or assign a dispensing pharmacy to your prescription.4,5

The compound and any branded pathway should be assessed separately. Compounded tirzepatide is not an FDA-approved finished product, and a named ingredient does not establish equivalence to a branded injection. Our compounding guide explains the distinction. Current pricing for a different branded product should not be inferred from this injection card.

Cancellation and refunds are different decisions

The FAQ says subscriptions may be canceled anytime without penalties and paused by notifying the care team in advance. It does not state a specific universal cancellation cutoff in the checked answers. Ask for written confirmation of the next charge and shipment before assuming an immediate request stops both.4

The first-month satisfaction guarantee is qualified by the same FAQ's statement that products are generally nonrefundable after shipment. The March 29, 2026 Terms separately say a delivered medical consultation is nonrefundable and prescription sales are final, with prescription-filling errors reported through the account. Clarify which part of the first purchase the guarantee covers; it should not be read as an unconditional right to return dispensed medicine.4,5

DecisionPublished condition
CancelFAQ: anytime without penalties; confirm next charge cutoff
PauseNotify care team in advance
First monthSatisfaction guarantee stated; exact covered portion needs confirmation
After shipmentFAQ generally excludes refunds
Consultation/prescriptionTerms: rendered consultation nonrefundable; prescription sales final
First-month satisfaction wording does not override every rendered-service or prescription restriction.

Check your state and ongoing support

The FAQ describes state-dependent availability and particular restrictions for sublingual products. Those restrictions should not automatically be transferred to this injection. Confirm the prescribed route, state eligibility, ingredients and dispenser directly with the care team. A public product listing and an application do not guarantee prescribing.4,5

Review side effects, gallbladder concerns and the thyroid warning with your clinician. Provider access and supplies can make a program easier to use, but they do not establish outcomes for its particular compounded preparation.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Compare the terms you will actually use

Our reviews of Concierge MD LA, Bioverse and Genesis Health describe each program's own preparation and payment terms. Use the provider comparison to compare full commitments, then confirm the accepted prescription and cancellation rules for the chosen program.

Frequently asked questions

Is Corsica tirzepatide $249 monthly?

That figure is the monthly equivalent of the $747 three-month plan. The product also lists a $299 one-month option. Confirm the accepted payment and renewal schedule.3

Will I be charged if treatment is not approved?

The product page says the card is charged only after approval by a licensed healthcare provider. That is a charging condition, not an unconditional refund after services or dispensing.3,5

Can I cancel or pause?

The FAQ permits cancellation anytime without penalties and pausing with advance notice to the care team. Ask when the next charge and shipment will be stopped.4

Does the first-month guarantee cover shipped medication?

The FAQ generally excludes refunds after shipment, and the Terms make consultation fees earned and prescription sales final. Confirm what the guarantee covers before relying on it.4,5

References(5)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Corsica Health (2026). Current named tirzepatide injection options and approval-before-charge condition (accessed October 26, 2026). Official provider public page.
  4. Corsica Health (2026). Current FAQ: provider roles, cancellation, pause and refund answers (accessed October 26, 2026). Official provider public page.
  5. Corsica Therapeutics LLC (2026). Terms of Use, March 29, 2026: clinical roles and payment restrictions (accessed October 26, 2026). Official provider public page.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.